Medical Plastic Systems
Gerresheimer is one of the leading specialists for the production of high-quality glass and plastic products for the international pharmaceutical and healthcare industry.
Gerresheimer Group
Global Provider of Systems and Solutions in Primary Packaging and Drug Delivery
Gerresheimer is a leading global partner to the pharma and healthcare industry. With special products made of glass and plastic, the company contributes to health and well-being. Gerresheimer is represented worldwide and produces with around 13,400 employees wherever its customers and markets are.
Subscribed
You have successfully submitted your enquiry. Someone from our company will respond ASAP
About Us
Gerresheimer is a global systems and solutions provider specialising in pharmaceutical packaging and drug delivery devices, offering the broadest product ranges in the pharmaceutical, healthcare, wellbeing, and biotechnology sectors. Our mission is to deliver all types of medications safely, reliably, and conveniently to or into patients.
Customers and partners worldwide present us with new challenges, and we stand as their solutions provider, committed to delivering at all points of development from concept to final product. This approach allows us to effectively meet the needs of our customers and, ultimately, their users.
Presence with local expertise
With over 40 production sites in 16 countries across Europe, America and Asia, Gerresheimer serves regional markets through localised manufacturing, ensuring proximity to customers and adherence to global quality standards. Together with Bormioli Pharma, the company employs approximately 13,400 people globally.
Extensive product portfolio
Gerresheimer offers a broad spectrum of systems and solutions such as vials, ampoules, cartridges, prefillable syringes, infusion and syrup bottles, and tablet containers, as well as closures and safety systems. Its product line extends to drug delivery devices, including insulin pens, autoinjectors, inhalers, micropumps, and digital therapy support systems, ensuring effective and user-friendly drug administration.
Integrated solutions across the healthcare value chain
Beyond being a packaging supplier, Gerresheimer is a strategic provider of systems and solutions, supporting customers throughout the entire product lifecycle—from initial concept development to market-ready delivery. Through a clearly defined portfolio of performance levels, Gerresheimer offers tailored solutions meeting diverse pharmaceutical and biotech industry requirements, ranging from standard applications to highly specialised therapies.
By combining innovation-focused design, high-quality manufacturing processes, and advanced features like specialised coatings, ready-to-fill systems, and digital traceability, Gerresheimer guarantees superior product integrity and process efficiency. This comprehensive approach enables pharmaceutical and biotech companies to bring therapies to patients efficiently, securely, and with uncompromising quality across the healthcare value chain.
Sustainability at the heart of innovation
Sustainability is a core element of Gerresheimer’s corporate strategy. Guided by its formula g strategy, the company integrates sustainable practices in every aspect of its operations, from resource-efficient production to the development of recyclable materials. Gerresheimer is dedicated to reducing the environmental impact of pharmaceutical packaging while maintaining the highest standards of safety and performance.
Global partner in health and drug delivery solutions
With a clear vision of becoming a global leader in health and drug delivery systems and solutions, Gerresheimer is driven by the values of teamwork, responsibility, integrity, bold innovation, and excellence. These principles guide our collaborations with customers and partners throughout the pharmaceutical industry.
For more information about Gerresheimer or any of our products or services, please contact us today via the enquiry form on this page.
White Papers
Update 3.1: Continuity of Business Guaranteed At All Times
During the Covid-19 pandemic, Gerresheimer is focusing on aspects including business continuity, customer demand, and supply chain. In 2019, we paved the way for profitable growth. We are investing and working to grow our innovation pipeline. These efforts continue undiminished.
More Than a Packaging Solution: Using High Quality Glass Vials to Improve Efficiency and Reduce Costs in Pharmaceutical Manufacturing
Glass containers, and glass vials in particular, have always played a fundamental role in the packaging of medicines.
Projects
Clariant Healthcare Packaging Plant, Cuddalore, Tamil Nadu
In January 2016, Switzerland-based speciality chemical company Clariant broke ground for its new manufacturing and healthcare packaging plant in Tamil Nadu, India.
Press Releases
Gerresheimer at CPHI Frankfurt 2025
Gerresheimer, a global systems and solutions provider specialising in pharmaceutical packaging and drug delivery devices, will present its extensive portfolio of high-value solutions for innovative therapies at this year’s CPHI Trade Fair in Frankfurt, Germany, from October 28th to 30th, 2025, in Hall 8 at Booth 8.OG8.
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, achieved solid results and continued to grow profitably in financial year 2024. Revenues reached €2,035.9m (2023: €1,990.5m), while adjusted EBITDA amounted to €419.4m (2023: €404.5m). Organic sales grew by +2.9% and adjusted EBITDA by +4.1%. The adjusted EBITDA margin improved to 20.6% (2023: 20.3%).
Two Stories, One Future: Gerresheimer and Bormioli Pharma at Pharmapack 2025
Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech and cosmetics industries, is presenting its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions for the first time together with Bormioli Pharma at this year's Pharmapack. The focus of the trade show appearance in Paris on 22 and 23 January 2025 will be on the further expanded portfolio of containment solutions with numerous closure options and accessories following the acquisition of Bormioli Pharma.
Gerresheimer Successfully Completes Acquisition of Blitz LuxCo, the Holding Company of the Bormioli Pharma Group
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions. Bormioli Pharma has a portfolio of pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems that is complementary to Gerresheimer.
Gerresheimer Builds New Production Capacities for Glass Syringes at Skopje Site
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetics industries, is expanding its production capacity in Skopje, North Macedonia, with a new production hall for syringes. Since 2019, Gerresheimer has been producing drug delivery systems, diagnostic and medical products made of plastic on around 14,600m² at this site. The new factory hall adds around 7,600m² of production space for glass syringes.
Gerresheimer Gx Elite Vials: Best Drug Protection and Production Efficiency
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, is presenting Gx Elite vials, designed to maximise patient safety and production efficiency through a quality by design approach. The main advantages of the product are its superior quality, which is reflected, for example, in its high breakage resistance and production efficiency. The advanced primary packaging solution is particularly suitable for sophisticated drugs such as biopharmaceuticals and innovative vaccines. Gx Elite vials can be delivered in bulk or pre-sterilised ready-to-fill in Gerresheimer’s innovative EZ-fill Smart packaging.
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has once again been awarded Gold by the sustainability rating provider EcoVadis. EcoVadis evaluates the management systems of companies in the categories of environment, labour and human rights, ethics, and sustainable procurement. More than 130,000 companies worldwide have their sustainability performance assessed by EcoVadis.
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma and biotech industry, will be presenting its innovative silicone oil-free prefillable syringe systems for ophthalmic applications at CPHI Worldwide 2024. The syringe systems made of glass or plastic ensure maximum compatibility even for sensitive ophthalmic drugs and offer outstanding functionality with precise dosage.
Gerresheimer Remains on Track in First Half of 2024
Gerresheimer, an innovative systems and solutions provider and global partner for the pharmaceutical, biotechnology and cosmetic industries, remains on track in the first half (H1) of FY 2024. Revenues reached €968.5m (H1 2023: €957.4m), adjusted EBITDA €188.2m (H1 2023: €185.2m). Revenue growth was 1.7% and adjusted EBITDA growth was 2.9% in organic terms. The adjusted EBITDA margin was 19.4%. Destocking effects for customers in the Primary Packaging Glass division were offset by the good revenue performance with a significantly improved margin in the Plastics & Devices division.
Gerresheimer Expands Capacities for Medical Systems in the USA
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States. In two expansion stages, Gerresheimer is expanding the production area at its Peachtree City site in the state of Georgia, USA, by around 18,000m² (194,000ft²).
Gerresheimer to Acquire Blitz Lux, the Holding Company of the Bormioli Pharma Group – Strategic Reset of Moulded Glass Business
Gerresheimer Glas, an indirect subsidiary of Gerresheimer, has today signed a purchase agreement with funds advised by Triton for the acquisition of Blitz Lux, the holding company of the Bormioli Pharma Group. The purchase price is based on a determined enterprise value of around €800m, which corresponds to an adjusted EBITDA multiple of around ten.
Gerresheimer Partners with RxCap to Offer Connected Adherence Solutions
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has entered into a partnership with the US digital health company RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor will receive the exclusive distribution rights for pharmacies in the US for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based software. Centor is the US market leader in prescription vials and is uniquely positioned to enable smart adherence solutions through existing pharmacy workflows.
Gerresheimer Makes Solid Start to the Financial Year 2024
Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries, continued its profitable growth trajectory in the first quarter of 2024 with organic revenue growth of 2.8% and an organic increase in adjusted EBITDA of 5.9%. This positive development was fueled primarily by the performance of the Plastics & Devices Division. Revenues came to € 466.1m (Q1 2023: € 457.8m), with adjusted EBITDA standing at €80.9m (Q1 2023: €78.0m). The adjusted EBITDA margin improved organically by 50 basis points to 17.3% year on year (Q1 2023: 16.8%).
Gerresheimer Performance Levels Simplify Choice of Optimum Solution
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, presents its new performance levels for injection vials, syringes, cartridges and ampoules. Within the relevant product category, customers can choose from three performance levels: Gx Value, Gx Advance and Gx Elite. The new structure makes it easier to select the right product platform according to the requirements for the pharmaceutical active agent or area of application. Gx Elite products offer the highest performance and are especially suitable for innovative biopharmaceutical products.
Gerresheimer Produces 100 Millionth Applicator for Organon Contraceptive Implant
Gerresheimer, an innovative system and solution provider and global partner to the pharma and biotech industries, recently produced at its Pfreimd location in Germany the 100 millionth sub-assembly for the current applicator for the Nexplanon contraceptive implant, a hormonal contraceptive from Organon.
Gerresheimer Decisively Continues on Profitable Growth Course in Financial Year 2023
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, decisively continued on its profitable growth course in the financial year 2023 with an organic revenue growth of 10.4% and a strong adjusted EBITDA growth of 17.5%. Revenues reached €1.99bn (2022: €1.82bn), the adjusted EBITDA €404.5m (2022: €354.2m).
Gerresheimer at Pharmapack 2024: Innovative Solutions and Expert Presentations
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industry, will present its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s Pharmapack. The company’s presence at the trade fair will focus on specialised primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, including cell and gene therapy products — from COP injection vials for cryogenic temperatures through to medication pumps.
Gerresheimer and Aptar Digital Health Collaborate to Develop Integrated Solution for Cancer Therapy
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, and Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programmes (PSPs) and disease management solutions, collaborate to develop an integrated solution for cancer therapy management. As part of this collaboration, the Gx SensAir on-body drug delivery device will be connected to Aptar Digital Health's software-as-a-medical device platform to improve the treatment experience and outcomes of cancer patients.
Gerresheimer: Green Electricity from Wind for German Production Sites
Gerresheimer, the innovative system and solution provider and global partner to the pharma, biotech and cosmetics industries, has signed a long-term electricity supply agreement with PNE, an international project planning company and wind turbine operator. The power purchase agreement (PPA), which covers around 35GWh of wind power per year, will enable Gerresheimer to reduce its CO₂ emissions by around 18,000t* each year starting in 2024.
Groundbreaking Ceremony for Plant Expansion in Querétaro, Mexico
Significant expansion of production capacities for RTF syringes for the North American market - investment volume of around €100m
Gerresheimer Awarded EcoVadis Gold Status Again
Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of businesses on environmental, labour and human rights, ethical, and sustainable procurement criteria.
Gerresheimer COP Vials: Ice-Cold Solution for the Challenges of Biologics
Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry launches with COP (Cyclic Olefin Polymer) vials a particularly satisfactory solution for the filling and storage of highly sensitive biologics. They are suitable for mRNA active ingredients at -80°C and cryogenic temperatures.
Gerresheimer on Track to Another Strong Financial Year
Gerresheimer, innovative provider of systems and solutions and global partner for the pharma, biotech, and cosmetics industries, made progress toward another strong financial year and a sustained improvement in profitability in the first nine months of 2023. Revenue grew organically (excluding exchange rate effects) by 12.6% year on year in the first nine months.
Gerresheimer Gx Elite Vials: Safely Putting Production in the Fast Lane
Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, is launching Gx Elite, a product line of glass injection vials designed to maximise patient safety and production efficiency. Top quality and shatter resistance are the key priorities of the range. The advanced primary packaging solution is particularly suitable for sophisticated drugs such as biopharmaceuticals and cytostatics.
Gerresheimer at CPHI: Focus on High-Value Solutions and Sustainability
Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, will present its extensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s CPHI Barcelona. The company’s presence at the trade fair will focus on specialised primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, cell and gene therapy products — from COP injection vials for cryogenic temperatures starting at -80°C through to medication pumps.
Gerresheimer Joins the Science Based Targets Initiative
Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry, has joined the Science Based Targets initiative (SBTi). The organisation supports companies in using sound science to set and work toward targets for reducing greenhouse gas emissions. The SBTi will verify whether Gerresheimer’s own CO₂ reduction targets are in line with the Paris Agreement before transparently documenting the company’s progress on its platform.
Continuing the Success Story
Gerresheimer expands Technical Competence Center in Wackersdorf with the addition of new Small Batch Production Sampling Area
Gerresheimer Launches Open Innovation Programme for the Development of Home Therapy Solutions
As an innovative system and solution provider, Gerresheimer is the global partner for the pharma and biotech industry. In collaboration with ekipa, a leading incubator for open innovation, Gerresheimer is calling on startups, companies, students, researchers and young professionals to enable or improve patient care at home with (digital) services and solutions. The best solution will be awarded €4,000 in prize money and the winner can work together with Gerresheimer on further development. The call for entries starts now and ends on 27 August 2023.
Gerresheimer Continues Dynamic Growth in First Half of 2023
- Organic revenue growth of 16.6% in first half of 2023 - Adjusted EBITDA up 23.0% organically - Production capacities expanded in Europe, the United States, and Mexico - Guidance for full year 2023 confirmed
Gerresheimer: Annual General Meeting Backs Growth Course
– Dividend of €1.25 per share after strong financial year 2022 – High approval rates for all agenda items – Forecast reaffirmed: double-digit growth in revenues and earnings
Successful FDA Inspection at Gerresheimer Peachtree City, USA
The Gerresheimer subsidiary in Peachtree City, USA, was named an approved “Contract Manufacturer for VERO Biotech’s GENOSYL Delivery System (DS), drug substance intermediate” for the disposable cassette of the company’s third generation of the first tankless inhaled nitric oxide delivery system. As part of the product’s approval on the American market, the entire manufacturing strategy was examined by the United States Food and Drug Administration.
Gerresheimer: Identifying Counterfeit Cosmetics Products by Using a Smartphone
Smartphone-ready authentication solution for cosmetic packaging
300 Years of Gerresheimer Essen – Tradition and Progress Successfully Combined
Today’s Gerresheimer Essen has been in existence since 1723, its origins going back to the ‘Royal Privileged Glass Manufactory’ founded 300 years ago. Today the company, as the production site of Gerresheimer, produces high-quality glass packaging for a large number of well-known customers in the pharmaceutical, cosmetics and food industries.
Gerresheimer 2022: Profitable Growth Company Boosting Revenue and Adjusted EBITDA Growth to Double-Digit Levels
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports double-digit growth in revenues and adjusted EBITDA for FY 2022. Revenue rose organically by 16.2%, driven by all divisions. Adjusted EBITDA grew organically by 10.2%.
Gerresheimer and Stevanato Group Announce Collaboration on the Development of an Innovative Ready-to-Use Vial Platform for the Pharmaceutical Industry
Gerresheimer, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics, and Stevanato Group (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announce that they have jointly developed a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology. This collaboration is projected to help customers gain efficiencies, improve the quality standard, increase speed to market, reduce total cost of ownership (TCO) and help mitigate supply chain risk.
Gerresheimer at Connect In Pharma: Safely Package and Administer Biotech and Pharmaceutical Products
At the premiere of Connect In Pharma, which takes place on 14 and 15 September in Geneva (Palexpo), Gerresheimer presents itself at booth A20. Gerresheimer is one of the founding partners of Connect in Pharma and will present its latest product solutions in the field of medical devices and packaging. A specialist lecture and a workshop will accompany the trade fair presentation.
Gerresheimer Boleslawiec Celebrates its 70th Anniversary
On 27 August, Gerresheimer Boleslawiec celebrates its 70th anniversary in Poland. Founded in 1952, the industrial plant called Polfa produced glass vials and ampoules. In 1997, Polfa was acquired by the Gerresheimer Group and renamed Gerresheimer Boleslawiec.
Gerresheimer Focuses on Sustainable Glass Production
As part of its global sustainability strategy, the Gerresheimer Group has set itself the goal of reducing its carbon dioxide (CO₂) emissions by 50% until 2030 compared with 2019. An important component of this endeavour is the use of state-of-the-art furnace technology in container glass production. The company produces high-quality glass packaging for the pharmaceutical, food and cosmetics industries at locations in Europe, America and Asia. Gerresheimer is currently replacing one of its two furnaces at the German plant in Tettau, Bavaria.
Gerresheimer on Track to Deliver Record Financial Year 2022 after Solid Second Quarter
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirms its guidance for its financial year 2022 after delivering a solid second quarter in line with plan. This rounded off the best first-half performance with organic revenue growth of 15.7 %. Adjusted EBITDA grew by 7.3%.
Gerresheimer Awarded EcoVadis Gold for Sustainable Corporate Management for the First Time
Gerresheimer has been awarded the gold medal for the first time by EcoVadis, one of the leading providers of sustainability rankings, for the successful implementation of its sustainability strategy. With 68 out of a maximum of 100 possible points, Gerresheimer is among the top 5% of all companies assessed by EcoVadis and among the best 2% in the industry. Gerresheimer has been awarded an EcoVadis silver medal in each of the past three years with steadily rising point values.
A New DPI Device for the Generic Drugs Market
MERXIN and Gerresheimer worked successfully together to realize the shortest possible time to market for the MERXIN MRX003 Capsule DPI
Gerresheimer Partners with MedTech Start-up Adamant Health to Revolutionise Treatment of Parkinson’s Disease
Gerresheimer and the Finnish MedTech startup Adamant Health partner up to develop a life-changing solution for millions of people worldwide suffering from Parkinson’s disease. The measuring technology and platform in development will address one of the biggest impediments in treating symptoms of Parkinson’s: determining the optimal time to take symptom suppressing medication.
Gerresheimer Traceability Solution: Full Transparency Right from the Beginning
Container-level traceability from production to point-of-care (PoC)
Gerresheimer Boosts Global Production Capabilities with New State-of-the-Art Facilities in India
Gerresheimer has significantly ramped up its glass and plastic production capacities in India. A new modern plant to produce high quality plastic containers and closures was built at the Kosamba site, and glass production received a new state-of-the-art and sustainable furnace technology. Both innovations were ceremonially commissioned by the management on the same day in April.
Gerresheimer at Pharmapack with the g guide: The Optimum Solution for Biotech and Pharma
Which packaging or delivery solution is best suited to the respective active ingredient? In addition to Gerresheimer's experts, the g guide has recently been answering this important question for customers and interested parties. At Pharmapack in Paris on 18 and 19 May, Gerresheimer will demonstrate the g guide for the first time at a trade fair on Stand B60/B64.
Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients with Innovative Needle-Free Drug-Delivery Solution
Gerresheimer AG is expanding its portfolio of highly-innovative platform technologies for drug delivery. Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced an investment into US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology. Together, the partners aim at transforming the administration of injectable medicines and improving the patient’s experience, especially for those with chronic diseases.
Gerresheimer Raises Revenue Guidance for 2022 to Double-Digit Growth after Strong First Quarter
First-quarter revenue grew organically by 19.1% Adjusted EBITDA up organically by 10.6% Gerresheimer raises revenue guidance to double-digit growth for 2022
Gerresheimer Awarded Platinum Status by Chiesi
Sustainability and product quality play an important role in this award from the international pharmaceutical company
Gerresheimer Opens a New Plant to Produce Pharmaceutical Container Solutions in Ohio (Berlin)
Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the Duma Twist-Off Q brand with a 40-ml filling volume, child-resistant closure, and desiccant for filling with medications for the North American market will be produced here in a clean room. The new building is Gerresheimer's eighth location in total on American soil and is being built directly next to Gerresheimer's prescription packaging production facility. A major customer of the company has now audited the site for its orders.
Gerresheimer Establishes Small Series Production in the USA
Pilot production in series quality at the Peachtree City production plant: Development samples, clinical samples all the way to small series production in every project phase for the company’s American customers
Ueli Utzinger Appointed New Group Senior Director Communication & Marketing at Gerresheimer
Ueli Utzinger is to become Gerresheimer AG’s new Group Senior Director Communication & Marketing as of December 1, 2021. He succeeds Jens Kürten, who is pursuing new opportunities after 12 years of successful marketing and communication work for the company.
Find the Right Packaging Solution Quickly and Easily with the Gerresheimer G Guide
Find the best packaging solution in no time at all: The g guide, Gerresheimer’s brand-new digital product selector, is now available on the Gerresheimer website. The g guide leads users to the ideal solution simply by asking a handful of questions. The new tool is aimed at potential customers in the pharmaceutical, biopharma and veterinary medicine industries.
Gerresheimer Enters Into Agreement with Major American Biotech to Develop an Innovative Pump for Rare Diseases
Gerresheimer has entered into an important agreement involving its Advanced Technologies division. An established US biotech company will rely on Gerresheimer's innovative strength and engineering expertise for the development of a new pump to deliver a leading drug for the treatment of rare diseases via continuous parenteral administration.
Gerresheimer Accelerates Growth and Raises Mid Term Guidance
Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, is further accelerating its profitable growth. The strategic program of formula G is realigning the business with megatrends such as healthcare, sustainability and biotech. Three years in implementing formula G to foster sustainable profitable growth, Gerresheimer has beaten its revenue guidance in 2021. Last year the company generated EUR 1,497m in core business revenues, achieving a strong organic growth of 7.6%. Core business adjusted EBITDA increased to EUR 324m on a currency-adjusted basis meeting the forecast range.
The Leading Supplier of Injection Vials, Gerresheimer, Expands Production in Wertheim
Gerresheimer is expanding its capacities for glass vials at the Wertheim site and at two further sites in China and the USA. The company is investing in production in Wertheim to increase vials capacity by 150 million vials per year and plans to create 70 new jobs for this purpose. The Federal Ministry of Economy and Climate Action supports the investment within the framework of federal funding of production equipment of borosilicate tubular glass and glass vials for use in vaccine production.
Gerresheimer Receives the Sustainability Heroes Award for its Sustainability Strategy
As part of the Sustainability Heroes Conference, the DQS and DGQ honored six companies with the Sustainability Heroes Awards. This year the choice in the category Sustainability Strategy fell on Gerresheimer. The company had applied for this award for the first time with its concept. Now Gerresheimer is one of the six companies selected by the jury from a total of 212 applications.
Innovations at Pharmapack 2021: Gx InnoSafe - The First Easy-Fill Syringe with Passive Needle Protection System
Nurses are among the occupational groups with the most frequent cuts and puncture wounds. This can lead to infection with dangerous pathogens such as hepatitis B and C viruses or HIV.
Pharmapack 2021: Gerresheimer with Innovative SensAIR Platform for a Drug Delivery Device for Biologics
With SensAIR, Gerresheimer presents an innovative platform for on-body drug delivery which can deliver drugs of higher viscosity, such as monoclonal antibodies (mAb). The aim is to provide patients with the best possible support in the subcutaneous delivery of large-volume biologics.
Gerresheimer Website Now Also in Chinese Language
Gerresheimer's website is now also available in Chinese. As demand for Gerresheimer's innovative and sustainable packaging solutions and drug delivery devices is also growing significantly in China and the company has six production sites in China, Gerresheimer wants to make it easier for its Chinese customers to access information on cooperation in this way.
Gerresheimer Builds India Production Plant for Plastic Containers
Gerresheimer has already been well-positioned in India for several years with Triveni Polymers Pvt Ltd in Kundli.
Metal-Free Glass Syringes for Biotechnologically Manufactured Active Ingredients with Patented Innovative Production Technology
Biotechnologically manufactured active ingredients demonstrate a series of special features. Some are highly viscous, concentrated and in individual cases, tend to interact with silicone oil or, for example, tungsten residue from syringe production.
Live at the CPhI China: Gerresheimer Presents Innovative Special Products for the Packaging and Administration Of Medicines
One of the most important events for pharmaceutical packaging and drug delivery in Asia is CPhI China. It will take place - LIVE - from 16 to 18 December 2020 in the well-known venue SNIEC Shanghai, at booth N5P21.
Gerresheimer Expands Range of Services in Asia
Medical technology specialist Gerresheimer is pleased to announce that it is extending its services portfolio in Asia.
Gerresheimer Includes Stevanato Group Integrated Twist-Off Closure System Solution for Gx RTF Syringes
Gerresheimer will offer its Gx RTF syringes with SG ITC (Integrated Tip Cap) twist-off closure of the Stevanato Group.
Development and Production of the Respimat® Reuseable Inhaler Housing Module
Boehringer Ingelheim commissioned Gerresheimer to develop and produce on a large scale the housing module for the new generation of Respimat® inhalers.
New Laboratory and Regulatory Services for Biotech Clients
Gerresheimer adds essential laboratory and regulatory services to its broad portfolio of products, solutions and services for biotech companies.
Gerresheimer Gradually Switches to Green Electricity
Since 1 June 2020, Gerresheimer has been supplying its plants in Wackersdorf, Pfreimd and Horšovský Týn with electricity which is obtained 100% from renewable energies, with the emphasis on hydroelectric power.
Injection Vials for Vaccines for Protection Against Covid-19
Covid-19 vaccines under development to protect from the disease are, like numerous other drugs, filled in injection or vials comprised of type 1 borosilicate glass.
Gerresheimer Supplies PET Bottles for Urgently Needed Hand Sanitiser
Hand sanitisers are currently urgently needed everywhere to protect against infection from coronavirus.
Gerresheimer Receives Sustainability Award from AstraZeneca
The two Gerresheimer production locations of Horšovský Týn and Pfreimd have been awarded gold status for the year 2019 by the customer AstraZeneca.
Centor Expands Storage Capacity
Gerresheimer Group company Centor Inc has laid the foundations for a brand new warehouse covering a total area of 72,000m2.
Gerresheimer and FM Plast Help Malteser Hilfsdienst by Donating Bottles and Caps for Disinfectants
Hand sanitiser is currently a scarce commodity. Malteser Hilfsdienst, a German aid organisation is now feeling the effect of this, as are many other health care facilities.
Pharmapack 2020: Innovative and Sustainable Packaging Solutions
As a leading specialist in drug packaging and administration, Gerresheimer has been a part of Pharmapack for many years.
Gerresheimer, Portal Instruments Develop Novel Primary Packaging
Gerresheimer Medical Systems, together with US-based Portal Instruments, has manufactured a new primary drug container for use in needle-free automatic injection systems.
Gerresheimer at Pharmapack
As a leading provider of speciality pharmaceutical packaging, Gerresheimer also specialises in manufacturing pharmaceutical containers made from type II glass.
Gerresheimer Increases Plastic Container Production, Opening India Plant
Gerresheimer has been positioned strongly in India for many years through Kundli’s Triveni Polymers Pvt Ltd.
CPhI India: Gerresheimer Clients Value Child-Resistant Pharma Packaging
Drugs are not intended to fall into the hands of children. However, in case this ever happens, it is essential to restrict them from being able to open the receptacles by fastening them with child-resistant caps.
Gerresheimer at CPhI Worldwide on 5-7 November
The Gx Elite vials and Gx RTF vials will be setting a new standard for type I vials made from borosilicate glass at booth 111B10 at CPhl Worldwide in Frankfurt from 5-7 November.
Gerresheimer to Launch Packaging Solution for Effervescent Vitamin C Tablets
At FCE Pharma in São Paulo, Gerresheimer will be showcasing a complete solution for packaging effervescent vitamin C tablets, which are currently seeing strong demand.
See Gerresheimer at CPhl North America
Gerresheimer has announced it will showcase innovative primary packaging and drug administration systems at CPhl North America.
Duma Standard Container - Childproof Packaging for Drugs
Gerresheimer will reveal its first snap-on cap with child-resistant (CR) solution at booth B62 at this year's Pharmapack.
Portal Instruments and Gerresheimer to Present at Pharmapack
Portal Instruments and Gerresheimer have announced they will be presenting a joint presentation titled: 'New Meets Old: Challenges and Solutions with Developing a Custom Primary Container'.
Gerresheimer Showcases Digital Drug Delivery Solutions at Pharmapack
In July of this year, Gerresheimer acquired Sensile Medical, expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.
Gerresheimer to Showcase Vials and Filling Performance at CPhI Worldwide
The Gx Elite vials have set new standards for Type 1 borosilicate glass vials. They are the result of comprehensive optimisation measures in the conversion process, which have focused on designing out the risk to create product flaws during production, including the removal of all glass-to-glass or glass-to-metal-contact beginning with the tubing material all the way through final packaging.
Gerresheimer to Expand its Services to Include Irradiation of Primary Packaging
Gerresheimer has announced it is expanding its range of services to include surface finishing of plastic packaging for ophthalmology and rhinology products with irradiation.
Gerresheimer and Sensile Medical to Attend CPhI Worldwide Together
By acquiring Switzerland-based Sensile Medical in July this year, Gerresheimer is expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.
Innovative Pharmaceutical and Biopharmaceutical Primary Packaging
Gerresheimer Gx Solutions is developing packaging solutions for the complex injectable drugs of tomorrow.
Gerresheimer at Medtec China
Gerresheimer develops and produces innovative drug delivery systems and medical and diagnostic products for prestigious international customers.
High-Quality Glass Containers for the Asian Pharmaceutical Industry
With a total of 13 sites across Asia for its range of glass and plastic products, Gerresheimer has announced it will be attending the Medipharm Expo this month.
Gerresheimer Expects Increased Growth and Improved Profitability Mid-Term
Gerresheimer has announced it expects increased growth and profitability mid-term due to two new major orders with temporarily higher capital index (capex) / organic revenue guidance 2018 narrowed to the upper end of the range.
Gerresheimer Showcases Innovative Packaging Solutions at CPhI China
Gerresheimer is presenting new products such as the Gx InnoSafe, the metal-free ready-to-fill (RTF) syringe, and RTF vials at the CPhI China trade fair in Shanghai.
Gerresheimer Expands Production in Brazil
Gerresheimer has announced that is has expanded its production capabilities at its plastic primary packaging manufacturing site in Anápolis, Goiás, Brazil.
Gerresheimer’s Indian Plants’ Products Meet Globally Recognised Standards
Gerresheimer’s Indian plants produce glass vials, ampoules and bottles that are specially designed for the storage of high-quality drugs.
Gerresheimer to Showcase Latest News and Innovations at CPhI South East Asia
Gerresheimer has announced it will be attending CPhI South East Asia, where it will be showcasing a range of innovations and company news, including the opening of its new tubular glass production plant in India for producing MultiShell vials.
Gerresheimer to Unveil Innovative Products at the PDA in Orlando
Gerresheimer’s booth at the PDA Annual Meeting will focus on innovative glass and plastic vials for parenteral drugs that place high demands on the barrier properties and the safety of their primary packaging.
Gerresheimer to Expand Development Centre in Wackersdorf to include Glass Products
Gerresheimer offers pharmaceutical and medical technology products of plastics and glass in its medical systems business unit.
Gx Elite vials – Type I Vials for Parenteral Drugs
The Gx Elite vials are type I vials that meet high standards. Made from borosilicate glass, the vials prevent any glass-to-glass and glass-to-metal contact. The chemical composition of the borosilicate glass is still the same. Gerresheimer will be showcasing its Gx Elite vials at booth 36 at the PDA in Rome on February 27 and 28.
Gerresheimer to Showcase Duma Standard CR With Handy Cap CR at Pharmapack, Paris
Gerresheimer has announced will be presenting its Duma Standard CR container, which features Handy Cap CR at Pharmapack.
Gerresheimer to Showcase Products at Pharma Expo Dhaka Trade Fair, Bangladesh
Gerresheimer has announced it will be attending the Pharma Expo Dhaka trade fair in Bangladesh, focusing on pharmaceutical primary packaging made from glass.
Gerresheimer Appoints Dr Lukas Burkhardt as New Member of the Management Board
Dr Lukas Burkhardt has been appointed to the management board of Gerresheimer effective 1 January.
Gx® InnoSafe: Greater Protection Against Needlestick Injuries
Gerresheimer will present their passive integrated safety system for avoiding needlestick injuries at Pharmapack in Paris.
Gerresheimer to Showcase Glass and Plastic Pharmaceutical Packaging Products at CPhI
Gerresheimer has announced it will be showcasing glass and plastic pharmaceutical packaging products that are Food and Drug Administration (FDA) registered and manufactured to stringent quality standards to the trade public at CPhI in Mumbai, India.
Gerresheimer's TE-ring Production to Commence
Gerresheimer has announced that production of its US dropper bottles with a fixed TE-ring will be operational in Q3.
Gerresheimer Medical Systems at Compamed
Gerresheimer Medical Systems has announced it will be attending the Compamed trade fair in Düsseldorf
Gerresheimer to Showcase Gx Elite Vials at CPhI Worldwide
Gerresheimer will be presenting its new type 1 borosilicate glass vial, Gx Elite, at CPhI Worldwide.
Gerresheimer Presents Integrated Safety System for the Prevention of Needlestick Injuries
With their exposed cannulas, used syringes are an omnipresent source of danger in medical practices, labs, or hospitals.
Gerresheimer to Showcase Stylish Opal Glass Solutions at LuxePack 2017
One of the most talked-about highlights from Gerresheimer's LuxePack trade fair showcase is opal glass.
Gerresheimer to Exhibit Packing Solutions for Healthcare Industry at Pack Expo 2017
Gerresheimer is pleased to announce it will be showcasing for the first time at this year's the Pack Expo trade fair, which is due to take place from 27-29 September in Las Vegas, Nevada.
Gerresheimer to Showcase at Pharmed & Healthcare Exhibition in Vietnam
Gerresheimer is pleased to announce it will be showcasing its tubular glass packaging at the Pharmed & Healthcare event from 20-23 September in Ho Chi Minh City, Vietnam.
Gerresheimer Receives Best Supplier Award from Mäurer & Wirtz
Gerresheimer is delighted to announce it was presented with the Best Supplier Award from its business partner Mäurer & Wirtz last month.
Pharmapack 2016: Green Pharmaceutical Packaging
Gerresheimer has released the first eco-friendly plastic containers for pharmaceutical and cosmetic applications, BioPack.
Gerresheimer Reports Good Third Quarter
Gerresheimer AG sustained its successful trend through the third quarter of the financial year.
Gerresheimer Concludes €425m Debt Issue
Gerresheimer AG has successfully wrapped up its refinancing with the launch of a debt issue (Schuldschein) for a total amount of €425m.
A Gerresheimer Long-Term Study Clarifies the Causes of Delamination
Temperature peaks in the manufacturing process are the main cause of delamination in tubular glass vials, which was discovered in a long-term study conducted by Gerresheimer AG and the Alfred University in New York.
Gerresheimer Launches an Eye Opener for Easy Use of Eye Droppers
People who use eye drops know how difficult they are to put in safely without assistance.
Gerresheimer Presents an Increased Barrier with Duma Twist-Off Advanced Container
Developers at Gerresheimer believe in making good products better, and are presenting an improved Duma Twist-Off container called Duma Twist-Off Advanced for solid pharmaceuticals.
Plastic Prefillable Syringes as an Alternative to Glass Syringes
Gerresheimer is one of only a few companies in the world to offer its customers both glass and COP syringes.
Interface Between Syringe and Device
Gerresheimer has developed an interface for the integration of glass syringes in autoinjectors. It has now filed a patent application for its Gx G-Fix standard adapter for precise and reliable positioning of syringes.
The Right Syringe for Every Application
The first time that most of us see a syringe and needle we are small babies and our mothers have taken us to the doctor to be vaccinated. Yet it is isn't just children who need vaccinations. For some diseases, we have to get vaccinated again as adults because the original vaccinations stop being effective after 20 years or so.
MultiShell Plastic Parenteral Vials from Gerresheimer
The new Gx MultiShell Plastic Vials overcome the specific limitations of plastic vials and combine superior properties of plastic and glass containers to a high-end container for parenterals.
Gerresheimer is Committed to Patient Safety
The American Academy of Ophthalmology endorses the uniform use of a colour-coding system for caps and labels on topical ocular medications. Topical medications are applied locally, for example eye drops and nasal drops.
How Ampoules are Made
Glass ampoules are ideal as a packaging for many cosmetic and pharmaceutical products. Gerresheimer incorporates its many years of experience in the meticulous production of ampoules to guarantee that they are safe to use and always in optimum quality.
Gerresheimer Plastic Packaging to Exhibit its Pharmaceutical Plastic Packaging Products at INTERPHEX
At this year's INTERPHEX, which will take place 20-22 April at the Jacob K Javits Convention Center in New York, Gerresheimer Plastic Packaging will be exhibiting its range of pharmaceutical plastic packaging products. Gerresheimer specialises in pharmaceutical and healthcare containers
New Quality Dimensions for Pharmaceutics: Gerresheimer Highlights Drug Delivery Products Made of Glass and Plastic
Tubular glass, moulded glass, plastic, intelligent syringe systems, high-quality vials and bottles, smart safety and application solutions: the whole world of pharma packaging was united in the Gerresheimer Group at Pharmtech Moscow, which was held at the Crocus Expo Center 24–27 November 2009. G
Gerresheimer Expands in the Global Pharmaceutical Plastic Business
The Gerresheimer Group recently expanded its activities in the pharmaceutical plastic business, through two strategically significant investments in the US and Europe. In September 2009 the company almost simultaneously opened a new research and development centre for medical plastic systems in t
Desiccant Concept Under the Duma Trademark Convinces the International Jury of the WPO
Gerresheimer receives the WorldStar for innovative pharma closures New standards for safety and economy Nomination for the President's Award For a highly innovative pharma closure system under the Duma trademark, Gerresheimer after receiving the 2007 German Packaging
Gerresheimer Presents Innovative Closure System for Tablet Containers
Everything from a single source for the pharmaceutics industry: the Gerresheimer Group again consistently builds on this principle in its plastic packaging business. The latest result of this development is a new tamper-evident closure system for tablet containers, which Gerresheimer manufactures
Products & Services
Ampoules
Gerresheimer's pharmaceutical ampoules are made with years of expertise and are in demand by customers worldwide.
Pharmaceutical Bottles
Gerresheimer manufactures an extensive range of glass and plastic bottles for the pharmaceutical industry.
Cartridges
Gerresheimer is an approved cartridges manufacturer for numerous applications in the pharmaceutical industry.
Syringe Systems
Gerresheimer manufactures a comprehensive range of pre-fillable syringes solutions, which can be ordered in bulk and ready-to-use formats.
Vials
Gerresheimer offers a complete range of vials from 0.6ml to 50ml in size.
Contact Details
Website
Email Address
Address
Peter-Müller-Str. 3,
40468 Düsseldorf,
Germany
40468 Düsseldorf,
Germany
Phone
Fax Number
Regional Offices
Address
Gerresheimer AG
Peter-Müller-Str. 3
40468 Düsseldorf
Germany
Website
Email address
Phone
Fax Number
Address
Gerresheimer Vaerloese A/S
Walgerholm 2-8
3500 Vaerloese
Denmark
Website
Email address
Phone
Address
Gerresheimer Chalon SAS
7, rue George Eastman BP 354
71109 Chalon-sur-Saône
France
Email address
Phone
Fax Number
Address
Gerresheimer Vaerloese A/S
43 Simpkin Close
Eaton Socon St. Neots
Cambridgeshire
PE19 8PD
Other
United Kingdom
Email address
Phone
Fax Number
Address
Gerresheimer Boleslawiec SA
ul. Boleslawa Chrobrego 15
PL-59-700 Boleslawiec
Other
Poland
Email address
Phone
Fax Number
Address
Gerresheimer Buenos Aires, S.A.
Mercedes 2153
C1417AUA Buenos Aires
Argentina
Email address
Phone
Fax Number
Address
Gerresheimer Momignies S.A.
Rue Mandenne 19/20
6590 Momignies
Belgium
Email address
Phone
Fax Number
Address
Gerresheimer Sistemas Plásticos Medicinais São Paulo Ltda.
Rua Vitório Emmanuel Soliani Nr. 190
Distrito Industrial Domingos Giomi
13347-380 Indaiatuba, São Paulo
Brazil
Email address
Phone
Fax Number
Address
Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd.
No. 35 East Road Fangxian
Danyang, Jiangsu Province
212321
China
Email address
Phone
Fax Number
Address
Neutral Glass & Allied Industries PVT. LTD.
Neutral Glass & Allied Inds. Pvt. Ltd.
902, Kamla Executive Park (Next to Vazir Glass Compound),
Off. M. Vasanji Road, J B Nagar,
Andheri (East), Mumbai – 400 059.
India
Email address
Phone
Fax Number
Address
Gerresheimer Querétaro S.A. (Primary Packaging Glass)
Av. Coahuila No. 9
Zona Industrial Benito Juárez
Santiago de Querétaro, Qro.
76120
Mexico
Email address
Phone
Fax Number
Address
Gerresheimer Singapore Pte. Ltd.
1 Harbourfront Place
Harbourfront Tower One
Unit #04-01
098633
Singapore
Email address
Phone
Fax Number
Address
Gerresheimer Horšovský Týn spol. s r.o.
Zahradní 282
34601 Horšovský Týn
Czech Republic
Email address
Phone
Fax Number
Address
Gerresheimer Zaragoza, S.A.
P.I. Valdemuel, Camino del Sabinar, s/n
50290 Epila (Zaragoza)
Spain
Email address
Phone
Fax Number
Address
Gerresheimer Küssnacht AG
Zugerstrasse 55
6403 Küssnacht
Switzerland
Email address
Phone
Fax Number
Address
Centor Inc.
1899 North Wilkinson Way
Perrysburg, OH 43551
United States of America
Email address
Phone
Related Content
